New FDA-Cleared JAK2 Biomarker Test for Blood Cancer Type
New biomarker test designed to aid diagnosis of patients suspected of having Polycythemia Vera form of blood cancer
New biomarker test designed to aid diagnosis of patients suspected of having Polycythemia Vera form of blood cancer
Dr Jim Huggett, LGC & University of Surrey, discusses the results of a study into international inter-laboratory digital PCR
First comparison of a biomarker analysis by RT-qPCR (MammaTyper®) versus visual or computer-assisted immunohistochemistry (IHC) in subtyping mammary carcinomas
Learn about the cutting-edge technology advancing cancer research
New service gives all researchers exclusive access to liquid biopsy-based tools
Circulogene’s core technology enables cell-free DNA monitoring in oncology
European launch of the new CE marked ipsogen CALR RGQ PCR Kit to improve MPN diagnosis for leukemia patients, in line with latest WHO recommendations and clinical guidelines